2026. Socio-Gerontological Perspectives on Disease-Modifying Alzheimer’s Therapies (Lecanemab): A Delphi Study in Central Europe. Journal of Health and Rehabilitation Sciences. 5, 1 (Jun. 2026), 8–16. DOI:https://doi.org/10.33700/jhrs.5.1.222.